Peri-implantitis is the number one challenge in implant dentistry, affecting 22% of implants (Herrera 2023). Managing peri-implantitis is challenging, unpredictable, and associated with significant morbidity. Therefore, the emphasis must be on prevention – utilizing new concepts and technologies.
The Patent™ Dental Implant System demonstrates that implant dentistry without peri-implantitis is achievable. Patent™ has been proven in two long-term studies to resist peri-implantitis (Brunello 2022, Karapataki 2023) – the first dental implant system ever to achieve this. Researchers at leading universities in Europe monitored two-piece Patent™ Implants for 9 and up to 12 years of function, reporting no peri-implantitis, even among patients with compromised health (diabetes, cancer, periodontitis, smokers).
Zero Peri-Implantitis around a two-piece dental implant: What’s the secret of Patent™? The key lies in the transmucosal implant surface, which is not machined, but has a unique micro- and macro-topography to promote strong soft-tissue adhesion. The result: A true bond forms between the soft tissue and the Patent™ surface, creating an effective defense barrier against plaque and bacteria.
If you too want to achieve implant treatments without peri-implantitis for your patients, visit the Patent™ booth at Dentex 2024, and visit www.mypatent.com to find more information.
